Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » FDA Letter Warns About False-Positive Results From Becton Dickinson SARS-CoV-2 Test

FDA Letter Warns About False-Positive Results From Becton Dickinson SARS-CoV-2 Test

Jul 07, 2020
|
staff reporter

NEW YORK ─ The US Food and Drug Administration on Monday issued a warning letter to clinical laboratory staff and healthcare providers to alert them about an increased risk of false-positive results from Becton Dickinson's BD SARS-CoV-2 reagents for its BD Max System test.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

From the Recovered

According to the Wall Street Journal, the Food and Drug Administration may soon issue an Emergency Use Authorization for convalescent plasma to treat COVID-19 patients.

Minnesota Cold Case Arrest

Minnesota police have used genetic genealogy to make an arrest in a 1986 cold case, reports NBC News.

Editing Squid

Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.

Science Papers Examine Human Fetal Microglia Development, Structure of Adenine Base Editor ABE8e

In Science this week: chromatin accessibility of microglia during fetal development, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.